Others use it for 1 to 2 years to reach their goals and then transition off while keeping their results through habits
doi: 10.1210/en.2007-1142
declares additional funding for this work through the UK Medical Research Council (MRC) (MR/T033371/1), and NIHR Development and Skills Enhancement Award (NIHR301616)
External resources New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) PubMed Central: Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity For researchers serious about optimizing their peptide protocols and navigating the rapidly shifting vendor landscape, SeekPeptides offers the most comprehensive resource available
Weight reductions exceeding 20% approach outcomes historically achievable only through bariatric surgery.
Additionally, combining cyclobenzaprine with other central nervous system depressants, such as alcohol, benzodiazepines, or opioids, can enhance the sedative effects, leading to increased drowsiness and potentially dangerous impairment of motor skills